AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
SLHN.SW
ACCE-researched

Swiss Life Holding AG (SLHN.SW) fair value

Financial Services · Insurance - Diversified · SIX · Switzerland
CHF 929.60-0.39%
Market cap CHF 26.0BNext earnings 2026-11-11Updated Oct 22, 2026
Our verdict
Trades 56% above our fair value
Price
CHF 929.60
Model fair valueConfidence: good
CHF 597
Model range
CHF 482 to CHF 736
Fair value CHF 597
Price CHF 930
3 models fit Swiss Life Holding AG and they disagree: 1 of 3 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as an insurer: Residual income, P/E comparison, and Dividend discount.
ACCE opinionSwiss Life Holding AG (SLHN.SW)
Fair value (3 models)
CHF 597
ACCE price target
CHF 903
Rating
Overvalued
Horizon
12 months
Fair value published on 22 Oct 2026, 12:04 CEST.
ACCE price target published on 22 Oct 2026, 16:00 CEST.
Rating published on 22 Oct 2026, 12:04 CEST.
Price used: CHF 930 at the close on 23 Oct 2026, 17:30 CEST.
Models: P/E comparison, Dividend discount, and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
55.7% above
-35.8% to fair value
ACCE score
57
out of 100
P/E
20.2x
forward 18.1x
1-year return
+6.8%
Dividend yield
3.91%

Swiss Life Holding AG in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Swiss Life writes life, pension and asset management business across Switzerland, France, Germany and Luxembourg, with its Swiss occupational pensions franchise and the Swiss Life Asset Managers platform as the two engines. The moat is a large, sticky base of Swiss BVG pension mandates and long-dated savings policies that renew through the cycle, which gives the group distribution depth that is hard to replicate quickly. Near-term growth rests on rising rates lifting reinvestment yields on the general account and on continued fee growth in asset management, though revenue growth of 3.4% is modest for the sector. At 20.3x trailing and 18.2x forward earnings, with a 19.4% return on equity, the stock is priced for steady compounding rather than a re-rating, so the case for a deeper look depends on whether that ROE holds as capital requirements tighten.

AI-assisted·How I use AIWritten Oct 23, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Heavy leverage on equity
    Debt/Equity of 2.01 means borrowings are about twice shareholder equity. For an insurer this is partly structural, but it leaves less cushion if markets or credit spreads turn.
  • moderate
    Long-run revenue decline
    Revenue has shrunk at a 7.5% CAGR over five years, even though the latest year shows +3.4%. Current growth is recovering from a weaker base, not a sustained trend.

AI research notes

AI-assisted·How I use AIWritten Oct 22, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Free cash flow over the last twelve months reached CHF 2.5B, a strong cash return for a company of this size.
  • A free cash flow yield of 9.5% at CHF 929.60 suggests the shares generate substantial cash relative to what investors pay.
  • The dividend yield of 3.9% gives income investors a meaningful cash payment while they wait for the shares to re-rate.
Why it could disappoint
  • Revenue has shrunk by an average of 7.5% a year over five years, which raises doubts about long-term growth.
  • Return on invested capital of 4.7% is weak, far below the 19.4% return on equity, pointing to heavy reliance on borrowing.
  • Earnings per share missed expectations by 7.8% in the latest quarter, and analysts' mean target sits 4.9% below the share price.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where SLHN.SW's valuation models land
Price
CHF 929.60
Model fair value
CHF 597
Model range
CHF 482 to CHF 736
Fair value CHF 597
Price CHF 930
The price is above the whole model range.
Model
Fair value
Upside
Dividend discount
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+0.3%
1 month
+2.7%
3 months
-1.6%
6 months
-0.1%
YTD
+1.4%
1 year
+6.8%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
22 Oct 2026, 16:00 CESTACCE price targetCHF 903first publicationCHF 929
22 Oct 2026, 12:04 CESTFair valueCHF 597first publicationCHF 929
22 Oct 2026, 12:04 CESTRatingOvervaluedfirst publicationCHF 929

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in CHF. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full SLHN.SW page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth48Value61Quality63Momentum56Total57
Valuation
Trailing P/E
20.2x
Forward P/E
18.1x
PEG
1.71
P/B
4.01x
EV / Revenue
1.4x
Book value/sh
CHF 225.94
Enterprise value
CHF 30.8B
Profitability
ROE
19.4%
FCF yield
9.56%
ROIC
4.7%
Health and risk
Debt / equity
2.01
Dividend yield
3.91%
Beta
0.53

Price

+6.7% · 1Y

Ask anything about SLHN.SW

Answered from Swiss Life Holding AG fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 33% of peers
low 8.0x20.2xhigh 41.8x
ROEbetter than 33% of peers
low 4%19%high 24%
Div yieldbetter than 83% of peers
low 0.0%3.9%high 5.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
SLHN.SW Swiss Life Holding AGCHF 929.60CHF 59756% above20.2x19.4%6357
ACGL Arch Capital Group Ltd. Common Stock$102.69$13826% below8.0x19.9%8760
AV.L Aviva plc£7.16--41.8x7.1%4353
TLX.DE Talanx AG€126.90€1292% below12.4x20.4%6556
SAMPO.HE Sampo€9.22€741% above14.4x24.1%8057
HIG The Hartford Insurance Group Inc. Common Stock$139.45$15510% below9.8x22.1%8073
HBAN.SW Helvetia Baloise Holding AGCHF 217.20CHF 99120% above40.4x3.9%4353

Sector report card

Where SLHN.SW ranks against its sector peers on each metric.

Computing percentiles…